Journal article
Prostacyclin receptor suppresses cardiac fibrosis: Role of CREB phosphorylation
EC Chan, GJ Dusting, N Guo, HM Peshavariya, CJ Taylor, R Dilley, S Narumiya, F Jiang
Journal of Molecular and Cellular Cardiology | Published : 2010
Abstract
Cardiac fibrosis is a consequence of many cardiovascular diseases and contributes to impaired ventricular function. Activation of the prostacyclin receptor (IP) protects against cardiac fibrosis, but the molecular mechanisms are not totally understood. Using mouse cardiac fibroblasts, we found that IP activation with cicaprost suppressed expression of collagen I and other target genes of transforming growth factor-β. This effect of cicaprost was unlikely to be mediated by inhibition of the Smad2/3 or mitogen-activated protein kinase (MAPK) activities, but was associated with cAMP elevation and phosphorylation of the transcription factor cAMP response element binding protein (CREB). Expressio..
View full abstractGrants
Funding Acknowledgements
This study is supported by project grants from the Australian National Health and Medical Research Council and Grants-in-Aid from the National Heart Foundation. ECH is supported by the Melbourne Research Fellowship from the University of Melbourne. GJD is a principal Research Fellow of NHMRC. We are grateful to Schering AG for supply of cicaprost and to Ono Pharmaceutical (Osaka) for providing the original ApoE<SUP>-/-</SUP>/IP<SUP>-/-</SUP> double knockout mice. We thank Miss Erika Duan for her excellent assistance on the preparation and staining of heart sections.